Pages that link to "Q69364366"

The following pages link to Passive and carrier-mediated intestinal absorption components of two angiotensin converting enzyme (ACE) inhibitor prodrugs in rats: enalapril and fosinopril (Q69364366):

Displaying 39 items.

• Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat (Q25257437) (← links)
• In-depth evaluation of Gly-Sar transport parameters as a function of culture time in the Caco-2 cell model. (Q33196489) (← links)
• Intestinal peptide transport systems and oral drug availability (Q33738294) (← links)
• Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption. (Q34017621) (← links)
• Delivery systems for penetration enhancement of peptide and protein drugs: design considerations (Q34190362) (← links)
• Angiotensin-converting enzyme inhibitors (Q34236623) (← links)
• Targeted prodrug design to optimize drug delivery (Q34461985) (← links)
• Transport of peptidomimetic drugs by the intestinal Di/tri-peptide transporter, PepT1. (Q34981676) (← links)
• Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery (Q35415314) (← links)
• The oligopeptide transporter hPepT1: gateway to the innate immune response (Q36465426) (← links)
• Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. (Q36535786) (← links)
• Permeation of four oral drugs through human intestinal mucosa (Q37146194) (← links)
• Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements (Q39205763) (← links)
• U373-MG cells express PepT2 and accumulate the fluorescently tagged dipeptide-derivative β-Ala-Lys-Nɛ-AMCA (Q39651847) (← links)
• Transport characteristics of L-carnosine and the anticancer derivative 4-toluenesulfonylureido-carnosine in a human epithelial cell line (Q40693986) (← links)
• Metabolism, uptake, and transepithelial transport of the stereoisomers of Val-Val-Val in the human intestinal cell line, Caco-2. (Q41153253) (← links)
• Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells (Q41364436) (← links)
• Current Concepts in Intestinal Peptide Absorption (Q41539834) (← links)
• First-Pass Effect: Significance of the Intestine for Absorption and Metabolism (Q41684485) (← links)
• Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors (Q41861130) (← links)
• The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC (Q41948835) (← links)
• Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans (Q51557257) (← links)
• A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 2: affinities of ACE inhibitors. (Q52068884) (← links)
• A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 1: system characterisation. (Q52068886) (← links)
• Stability, metabolism and transport of D-Asp(OBzl)-Ala--a model prodrug with affinity for the oligopeptide transporter. (Q52222028) (← links)
• Development of a QSAR Model for Binding of Tripeptides and Tripeptidomimetics to the Human Intestinal Di-/Tripeptide Transporter hPEPT1 (Q62648677) (← links)
• Molecular Determinants of Recognition for the Intestinal Peptide Carrier (Q62779112) (← links)
• Comparison of fosinopril and hydrochlorothiazide in patients with mild to moderate hypertension (Q67905114) (← links)
• Structural requirements for the intestinal mucosal-cell peptide transporter: the need for N-terminal alpha-amino group (Q67936342) (← links)
• Peptide carrier-mediated transport in intestinal brush border membrane vesicles of rats and rabbits: cephradine uptake and inhibition (Q70639735) (← links)
• Mechanisms of transport of quinapril in Caco-2 cell monolayers: comparison with cephalexin (Q71575296) (← links)
• Suitability of enalapril as a probe of the dipeptide transporter system: in vitro and in vivo studies (Q71616243) (← links)
• Depsipeptide (FR901228, NSC-630176) pharmacokinetics in the rat by LC/MS/MS (Q73916887) (← links)
• CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs (Q74533535) (← links)
• Structure-transport relationship for the intestinal small-peptide carrier: is the carbonyl group of the peptide bond relevant for transport? (Q78018823) (← links)
• Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs (Q78498262) (← links)
• Dog colonoscopy model for predicting human colon absorption (Q79750339) (← links)
• Use of classification regression tree in predicting oral absorption in humans (Q81035525) (← links)
• The effect of cephalexin in influencing the pharmacokinetics of a novel drug - 5'-valyl-cytarabine hydrochloride (Q89909557) (← links)